Specialty Pharmaceuticals Company Salix Pharmaceuticals is committed to providing treatments for a wide spectrum of gastrointestinal disorders.
Posted on 01 October 2014
Specialty Pharmaceuticals Company Salix Pharmaceuticals is committed to providing treatments for a wide spectrum of gastrointestinal disorders.
Posted on 29 September 2014
Genmab, a top big biotech company, headquartered in Denmark is one of the leaders today in the human antibody therapeutics market for cancer treatment.
Posted on 28 September 2014
Salix Pharmaceuticals has announced 3 M&A deals since 2009, with the deals being the acquisition of Santarus, Oceana Therapeutics and the merger between Salix and Cosmo Pharmaceuticals.
Posted on 22 September 2014
MorphoSys, a leader in antibody drug discovery, has emerged as a top 50 big biotech company with its product pipeline and partnering strategy.
Posted on 19 September 2014
Genmab is an internationally recognised biotechnology company developing human antibody therapeutics primarily for cancer.
Posted on 15 September 2014
Isis Pharmaceuticals, a leader in antisense drug discovery, has emerged as a top 50 big biotech company with its business strategy.
Posted on 12 September 2014
MorphoSys has announced only one acquisition in the past 5 years.
Posted on 08 September 2014
Headquartered in Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceuticals company that has undergone significant growth in recent years. Jazz Pharmaceuticals is focused upon delivering products for cataplexy, narcolepsy, oncology/leukemia, chronic pain and non-opioid schizophrenia.
Posted on 02 September 2014
Isis Pharmaceuticals is an antisense drug discovery technology company developing therapies for a number of serious diseases.
Posted on 01 September 2014
Jazz Pharmaceuticals, listed as a new big biotech entrant in 2014, has announced 3 M&A deals since 2009, with the lead deals being the acquisitions of Gentium and merger with Azur Pharma.